Latest Nerve agent Stories
NYU Researchers Advance the Stability of a Protein that Neutralizes Toxins in Common Pesticides and Chemical Weapons NEW YORK, July 31, 2014 /PRNewswire/ -- Research at New York University
ANNAPOLIS, Md., June 9, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that the U.S. Patent and Trademark Office issued U.S.
A new report from a Congressionally-mandated panel of scientific experts and veterans has found that Gulf War illness is most likely the result of exposure to toxins. The panel added research surrounding treatment of the condition has been advancing at an “encouraging” rate.
Therapure Biopharma Inc., a contract development and manufacturing organization (CDMO) of biotherapeutics, is pleased to announce the company will participate as a subcontractor for DynPort Vaccine
The latest episode in the American Chemical Society's (ACS) award-winning "Global Challenges/Chemistry Solutions" podcast series describes the development of a new test that could help track down and prosecute terrorists.
Gulf War Illness (GWI)—the chronic health condition that affects about one in four military veterans of the 1991 Gulf War—appears to be the result of several factors, which differed in importance depending upon the locations where veterans served during the war.
The brain is forever chattering to itself, via electrical impulses sent along its hard-wired neuronal "Ethernet".
SILVER SPRING, Md., Sept. 9 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents).
ABERDEEN PROVING GROUND, Md., April 26 /PRNewswire/ -- The U.S. Army Edgewood Chemical Biological Center (ECBC), the premier national resource for chemical and biological defense, announced that the U.S.
- A volcanic mudflow.